The Food and Drug Administration approved Abiomed Inc.'s (Nasdaq: ABMD)
Impella 2.5 heart pump sending the stock price soaring $12.22 to $73.65.
FDA approves Abiomed's Impella 2.5
March 24, 2015 at 14:23 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.